Depotech(depo) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo)

DEPO 7.300

+1.7%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BD who wrote (702)	2/9/1998 12:45:00 PM
From: Jasman	Read Replies (1) of 887

My speculation is... Depotech will (at the minimum) get approval for Depocyt with conditions. I have looked at the results and the efficacy and safety are not a problem. When Depotech meets with the FDA, presumably at the end of February, Depotech will persuade the FDA that the Phase III trials can be repeated. The reason the FDA failed to approve Depocyt lies on several unexplainable parameters of the Phase III trials. Check out past news of Depotech at Reuters Health and News web page (http://www.reutershealth.com/) and you will see what I mean. You will need to subscribe. Phase IV trials will prove that Phase III trials were legitimate. At current levels, any signs of hope will significantly boost the share price. Depotech is a outright steal under $4.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next